Stephen Bardin
Förmögenhet: 43 000 $ per 2026-07-31
Förmögenhet: 43 000 $ per 2026-07-31
Stephen Bardin is currently Chief Financial & Accounting Officer at CalciMedica, Inc. since 2024.
Formerly, Mr. Bardin was Chief Financial Officer at Atai Beckley NV from 2022 to 2023.
From 2019 to 2022, Mr. Bardin was Senior Vice President-Finance & Operations at BridgeBio Pharma, Inc., and also held the position of Senior Vice President-Operations & Finance at BridgeBio Pharma, Inc. Mr. Bardin completed undergraduate studies at Duke University and earned an MBA from Stanford Graduate School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CALCIMEDICA, INC. 0,14 % | 2025-06-26 | 43 000 ( 0,14 % ) | 43 000 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| CALCIMEDICA, INC. | Finansdirektör/CFO | 2024-11-01 |
| Företag | Position | Slut |
|---|---|---|
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Finansdirektör/CFO | 2023-10-13 |
| BRIDGEBIO PHARMA, INC. | Företagsledare/Principal | 2022-06-01 |
| BRIDGEBIO PHARMA, INC. | Finansdirektör/CFO | 2022-06-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
CalciMedica, Inc.
CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån